Brandtree

Who owns Zero-Cal?

Zero-Cal is owned by Hypera (Brazil, B3: HYPE3).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Key facts

Current owner
Hypera Pharma reported
Owned since
Not recorded
Previous owner
None recorded
Owner HQ
🇧🇷 Brazil, São Paulo
Origin
🇧🇷 Brazil
Category
FoodCondiments, sauces & seasoningsSweeteners
Parent ticker
B3: HYPE3
Last verified
· 1 sources

About Zero-Cal

Zero-Cal is Hypera Pharma's tabletop sweetener brand, which the company calls the leading sweetener brand. It sells saccharin, sucralose, stevia and xylitol sweeteners in liquid and powder form, and added the Zero-Cal Bem Natural line based on erythritol made from non-GMO corn. Hypera groups it with its nutritionals in the consumer health unit.

Ownership timeline of Zero-Cal

  1. ? – present Hypera [1] reported

Where Zero-Cal sits in Hypera

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Zero-Cal sits in Hypera Tree of 8 brands under Hypera. Hypera Zero-Cal Benegrip Biotônico Fontoura Doril Engov Epocler and 2 more

Open the full Hypera ownership tree →

Other brands owned by Hypera

See the full Hypera brand portfolio (8) →

Latest news about Zero-Cal

No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.

Headlines link to the original publisher. Brandtree does not reproduce article text.

Frequently asked questions

Who is the parent company of Zero-Cal?

The parent company of Zero-Cal is Hypera, a publicly listed company headquartered in Brazil.

Is Zero-Cal Brazilian?

Yes. Zero-Cal originated in Brazil and its owner, Hypera, is also headquartered in Brazil.

Is Zero-Cal still owned by Hypera?

Yes. As of 16 September 2026, Zero-Cal is still owned by Hypera. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026) — Hypera Pharma, Official document, published 18 June 2026; retrieved 16 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.